Skip to main content
WX

www.xinthera.com

The startup develops precision medicines using computational chemistry to create targeted therapies for cancer and immunologic diseases. By focusing on well-validated targets that have been difficult to treat, the company aims to provide effective drug options for patients with limited existing therapies.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • The startup develops precision medicines using computational chemistry to create targeted therapies for cancer and immunologic diseases. By focusing on well-validated targets that have been difficult to treat, the company aims to provide effective drug options for patients with limited existing therapies.
This profile is AI-generated and may contain inaccuracies.